Page last updated: 2024-11-11

vernoleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vernolic acid : A monounsaturated epoxy fatty acid composed of cis-9-octadecenoic acid having a 12,13-epoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

(+)-vernolic acid : An optically active form of vernolic acid having (12S,13R)-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6449780
CHEBI ID27706
SCHEMBL ID55116
MeSH IDM0216507

Synonyms (48)

Synonym
vernoleate
cis-12-epoxyoctadeca-cis-9-enoate
9-undecenoic acid, 11-(3-pentyloxiranyl)-, (2s-(2alpha(z),3alpha))-
fr42854epw ,
unii-fr42854epw
(9z)-(12s,13r)-12,13-epoxyoctadecenoic acid
vernolic acid
503-07-1
CHEBI:27706
(9z)-11-[(2s,3r)-3-pentyloxiran-2-yl]undec-9-enoic acid
(+)-12(s),13(r)-vernolic acid
12s,13r-epome
cis-12-epoxyoctadeca-cis-9-enoic acid
vernolic acid (+)-form
(+)-vernolsaeure
(+)-leukotoxin b
(+)-vernolic acid
4s5jf40zoq ,
leukotoxin b
cis-12,13-epoxyoleic acid
isoleukotoxin
vernolic acid, cis-(+/-)-
unii-4s5jf40zoq
9-undecenoic acid, 11-(3-pentyloxiranyl)-, (2alpha(z),3alpha)-
9-undecenoic acid, 11-((2r,3s)-3-pentyl-2-oxiranyl)-, (9z)-rel-
(z)-11-[(2s,3r)-3-pentyloxiran-2-yl]undec-9-enoic acid
LMFA02000282
12s,13r-epoxy-9z-octadecenoic acid
(+/-)12(13)-epome
9-undecenoic acid, 11-((2s,3r)-3-pentyl-2-oxiranyl)-, (9z)-
(+)-12,13-epoxy-9-cis-octadecenoic acid
vernolic acid (+)-form [mi]
vernolic acid, cis-(+)-
octadec-cis-(+)-12,13-epoxy-cis-9-enoic acid
oleic acid, 12,13-epoxy-, (12s,13r)-(+)-
cis-(+)-12,13-epoxyoctadec-cis-9-enoic acid
vernoleic acid
9-undecenoic acid, 11-(3-pentyloxiranyl)-, (2.alpha.(z),3.alpha.)-
SCHEMBL55116
CCPPLLJZDQAOHD-GJGKEFFFSA-N
DTXSID40895851
cis-(+)-vernolic acid
Q28530676
cis-12,13-epoxy-9(z)-octadecenoic acid
sr-01000946972
SR-01000946972-1
iso-leukotoxin
(+/-)-vernolic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
vernolic acidA monounsaturated epoxy fatty acid composed of cis-9-octadecenoic acid having a 12,13-epoxy group.
oxylipinAny member of the group of bioactive lipids made by oxidation of polyunsaturated fatty acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (33.33)18.2507
2000's10 (47.62)29.6817
2010's3 (14.29)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.32 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]